CD274 and myocardial infarction: Thus, the challenge remains how to harness the beneficial effects of cardiac PD-1/PD-L1 activation while preventing/reducing its deleterious effects on cardiac cells (in myocardial infarction and conditions associated with ischemia-reperfusion injury to the heart such as coronary artery bypass and cardiac transplantation).